A statement released Wednesday by Synopharm subsidiary Beijing Biological Products Institute Co., Ltd. said that interim analysis of Phase 3 clinical trials showed that the vaccine was safe and that those receiving two doses produced high-level antibodies. The company said it was seeking formal formal approval from Chinese regulators to …
Read More »China’s Synopharm says its coronavirus vaccine is 79% effective
